Summary
In vivo administration to diabetic-hypophysectomized rats of either the growth factor produced by the plerocercoid larvae of the tapeworm, Spirometra mansonoides, or mammalian growth hormone caused inhibition of hepatic drug metabolism measured in vitro.
Similar content being viewed by others
References
D. E. Cook and C. K. Phares, Biochem. Pharmac.24, 1919 (1975).
E. Wei and J. T. Wilson, J. Pharmac. exp. Ther.177, 227 (1971).
R. L. Dixon, L. G. Hart and J. R. Fouts, J. Pharmac. exp. Ther.133, 7 (1961).
R. L. Dixon, L. G. Hart, L. A. Rogers and J. R. Fouts, J. Pharmac. exp. Ther.142, 312 (1963).
T. J. Merimee and D. Rabin, Metabolism22, 1235 (1973).
A. Hyrärinen and E. A. Nikkila, Clinica chem. Acta7, 140 (1963).
J. F. Mueller, J. Parasit.55, 167 (1968).
C. R. Morgan, and A. Lazarow, Diabetes14, 669 (1965).
R. O. Scow, Endocrinology61, 582 (1957).
W. R. Ruegamer and J. F. Mueller, J. Nutr.103, 1496 (1973).
D. R. Harlow, W. Mertz and J. F. Mueller, J. Parasit.53, 449 (1967).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cook, D.E., Phares, C.K. Effect of growth factors on hepatic drug metabolism in diabetic-hypophysectomized rats. Experientia 33, 1110–1111 (1977). https://doi.org/10.1007/BF01946000
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01946000